Insulin Pumps Gain Popularity in US, Offering Precise Dosing and Convenience
Insulin pumps, wearable devices delivering continuous insulin, are gaining popularity in the United States. Around 350,000 people use them, predominantly those with type 1 diabetes. They offer precise dosing and communication with glucose monitors, but require learning and practice.
An insulin pump consists of a display screen, insulin cartridge holder, and a thin cannula inserted under the skin. It mimics a human pancreas, delivering programmed insulin doses. Benefits include no daily injections and automatic adjustments with some models.
Drawbacks include higher cost and potential malfunctions. Learning to use one involves guidance from diabetes educators or doctors, covering attachment, insulin changes, troubleshooting, and feature management. Current US options include Medtronic Minimed 780G/770G, Omnipod 5, Tandem t:slim X2, and Tandem Mobi. By 2025, expect the YpsoPump, Medtronic Paradigm/508, and Dana-i system. Innovations bring features like automatic adjustments, touchscreens, waterproofing, and Bluetooth connectivity.
Insulin pumps provide a convenient, precise alternative to injections. Despite drawbacks and higher cost, they're a popular choice for many with diabetes. As technology advances, more options and features are expected by 2025.
